Regulation of PDL-1 expression in thyroid carcinoma cells by tumor cell derived cytokines activating STAT3
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Regulation of PDL-1 expression in thyroid carcinoma cells by tumor cell derived cytokines activating STAT3 ; volume:73 ; number:1 ; day:19 ; month:12 ; year:2024 ; pages:1-9 ; date:12.2025
Immunologic research ; 73, Heft 1 (19.12.2024), 1-9, 12.2025
- Urheber
-
Klemke, Matthias
Veit, Nadine
Schmidt-Wolf, Ingo
Bundschuh, Ralph A.
Essler, Markus
Kreppel, Barbara
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12026-024-09552-y
- URN
-
urn:nbn:de:101:1-2503020603264.516987080335
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Klemke, Matthias
- Veit, Nadine
- Schmidt-Wolf, Ingo
- Bundschuh, Ralph A.
- Essler, Markus
- Kreppel, Barbara
- SpringerLink (Online service)
Ähnliche Objekte (12)
"PDL
Overexpression of RPN2 suppresses radiosensitivity of glioma cells by activating STAT3 signal transduction
PDL kompakt
PDL kompakt
S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway
STAT3, stem cells, cancer stem cells and p63
CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway
A novel activating role of SRC and STAT3 on HGF transcription in human breast cancer cells
WNT7A promotes tumorigenesis of head and neck squamous cell carcinoma via activating FZD7/JAK1/STAT3 signaling
IGFBP2/ITGA5 promotes gefitinib resistance via activating STAT3/CXCL1 axis in non-small cell lung cancer
Zinc finger protein 263 promotes colorectal cancer cell progression by activating STAT3 and enhancing chemoradiotherapy resistance
IDH2/R140Q mutation confers cytokine-independent proliferation of TF-1 cells by activating constitutive STAT3/5 phosphorylation
"PDL
Overexpression of RPN2 suppresses radiosensitivity of glioma cells by activating STAT3 signal transduction
PDL kompakt
PDL kompakt
S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway
STAT3, stem cells, cancer stem cells and p63
CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway
A novel activating role of SRC and STAT3 on HGF transcription in human breast cancer cells
WNT7A promotes tumorigenesis of head and neck squamous cell carcinoma via activating FZD7/JAK1/STAT3 signaling
IGFBP2/ITGA5 promotes gefitinib resistance via activating STAT3/CXCL1 axis in non-small cell lung cancer
Zinc finger protein 263 promotes colorectal cancer cell progression by activating STAT3 and enhancing chemoradiotherapy resistance
IDH2/R140Q mutation confers cytokine-independent proliferation of TF-1 cells by activating constitutive STAT3/5 phosphorylation
"PDL
Overexpression of RPN2 suppresses radiosensitivity of glioma cells by activating STAT3 signal transduction
PDL kompakt
PDL kompakt
S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway
STAT3, stem cells, cancer stem cells and p63
CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway
A novel activating role of SRC and STAT3 on HGF transcription in human breast cancer cells
WNT7A promotes tumorigenesis of head and neck squamous cell carcinoma via activating FZD7/JAK1/STAT3 signaling
IGFBP2/ITGA5 promotes gefitinib resistance via activating STAT3/CXCL1 axis in non-small cell lung cancer
Zinc finger protein 263 promotes colorectal cancer cell progression by activating STAT3 and enhancing chemoradiotherapy resistance